David Zaccardelli is President and CEO of Verona Pharma plc. Currently has a direct ownership of 14.2 Million shares of VRNA, which is worth approximately $855 Million. The most recent transaction as insider was on Aug 07, 2024, when has been sold 800,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2M
0.23% 3M change
10.69% 12M change
Total Value Held $855 Million

DAVID ZACCARDELLI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2024
BUY
Grant, award, or other acquisition
-
800,000 Added 4.61%
16,565,504 Ordinary Shares
Aug 01 2024
SELL
Payment of exercise price or tax liability
$250,579 $2.83 p/Share
88,544 Reduced 0.56%
15,765,504 Ordinary Shares
May 01 2024
SELL
Payment of exercise price or tax liability
$170,889 $1.93 p/Share
88,544 Reduced 0.56%
15,854,048 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$1,099,658 $2.29 p/Share
480,200 Reduced 2.92%
15,942,592 Ordinary Shares
Nov 01 2023
SELL
Payment of exercise price or tax liability
$1,407,673 $1.74 p/Share
809,008 Reduced 4.69%
16,422,792 Ordinary Shares
Oct 20 2023
BUY
Grant, award, or other acquisition
-
800,000 Added 4.44%
17,231,800 Ordinary Shares
Aug 07 2023
SELL
Open market or private sale
$21,281 $2.47 p/Share
8,616 Reduced 0.05%
16,431,800 Ordinary Shares
Aug 04 2023
SELL
Open market or private sale
$375,000 $2.5 p/Share
150,000 Reduced 0.9%
16,440,416 Ordinary Shares
Aug 03 2023
SELL
Open market or private sale
$297,870 $2.54 p/Share
117,272 Reduced 0.7%
16,590,416 Ordinary Shares
Aug 02 2023
SELL
Open market or private sale
$190,893 $2.59 p/Share
73,704 Reduced 0.44%
16,707,688 Ordinary Shares
Aug 01 2023
SELL
Open market or private sale
$283,929 $2.68 p/Share
105,944 Reduced 0.63%
16,781,392 Ordinary Shares
May 01 2023
SELL
Open market or private sale
$1,175,282 $2.58 p/Share
455,536 Reduced 2.63%
16,887,336 Ordinary Shares
Feb 01 2023
SELL
Open market or private sale
$1,108,295 $2.56 p/Share
432,928 Reduced 2.44%
17,342,872 Ordinary Shares
Dec 20 2022
SELL
Open market or private sale
$1,272,000 $2.12 p/Share
600,000 Reduced 3.27%
17,775,800 Ordinary Shares
Nov 01 2022
SELL
Payment of exercise price or tax liability
$727,769 $1.6 p/Share
454,856 Reduced 2.41%
18,408,704 Ordinary Shares
Nov 01 2022
SELL
Open market or private sale
$54,949 $1.67 p/Share
32,904 Reduced 0.18%
18,375,800 Ordinary Shares
Sep 26 2022
BUY
Grant, award, or other acquisition
-
3,600,000 Added 16.03%
18,863,560 Ordinary Shares
Aug 09 2022
SELL
Open market or private sale
$1,050,000 $1.75 p/Share
600,000 Reduced 3.78%
15,263,560 Ordinary Shares
Aug 01 2022
SELL
Open market or private sale
$23,033 $0.7 p/Share
32,904 Reduced 0.21%
15,863,560 Ordinary Shares
Aug 01 2022
SELL
Payment of exercise price or tax liability
$304,759 $0.67 p/Share
454,864 Reduced 2.78%
15,896,464 Ordinary Shares
May 03 2022
SELL
Open market or private sale
$16,452 $0.5 p/Share
32,904 Reduced 0.2%
16,351,328 Ordinary Shares
May 01 2022
SELL
Payment of exercise price or tax liability
$236,529 $0.52 p/Share
454,864 Reduced 2.7%
16,384,232 Ordinary Shares
Feb 03 2022
SELL
Open market or private sale
$38,001 $0.73 p/Share
52,056 Reduced 0.31%
16,839,096 Ordinary Shares
Feb 01 2022
SELL
Payment of exercise price or tax liability
$225,145 $0.78 p/Share
288,648 Reduced 1.68%
16,891,152 Ordinary Shares
Feb 01 2022
BUY
Grant, award, or other acquisition
$250,836 $0.75 p/Share
334,448 Added 1.91%
17,179,800 Ordinary Shares
DZ

David Zaccardelli

President and CEO
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA